Rafal, Guillermo, Jr. S.
HRN: 22-68-27 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/27/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
02/27/2023
03/06/2023
IV
600mg
Q6h
Fracture
Waiting Final Action
Indication: Empiric Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes